Free Trial

Voleon Capital Management LP Invests $1.14 Million in Chemed Co. (NYSE:CHE)

Chemed logo with Medical background

Voleon Capital Management LP acquired a new stake in shares of Chemed Co. (NYSE:CHE - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,144 shares of the company's stock, valued at approximately $1,136,000.

Other hedge funds have also recently made changes to their positions in the company. Schonfeld Strategic Advisors LLC boosted its holdings in Chemed by 16.3% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 520 shares of the company's stock worth $275,000 after buying an additional 73 shares in the last quarter. AQR Capital Management LLC raised its stake in Chemed by 18.0% in the 4th quarter. AQR Capital Management LLC now owns 80,665 shares of the company's stock valued at $42,736,000 after purchasing an additional 12,300 shares during the last quarter. Northern Trust Corp lifted its stake in shares of Chemed by 19.3% in the fourth quarter. Northern Trust Corp now owns 208,535 shares of the company's stock worth $110,482,000 after buying an additional 33,710 shares in the last quarter. Second Half Financial Partners LLC acquired a new position in Chemed during the fourth quarter worth about $478,000. Finally, Susquehanna Fundamental Investments LLC purchased a new stake in Chemed during the 4th quarter valued at about $2,575,000. 95.85% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CHE has been the topic of several analyst reports. Royal Bank of Canada lifted their price target on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a report on Monday, April 28th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Check Out Our Latest Stock Analysis on Chemed

Chemed Stock Up 0.1 %

Chemed stock traded up $0.62 during mid-day trading on Monday, hitting $576.08. The company had a trading volume of 126,659 shares, compared to its average volume of 99,783. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $623.61. The stock has a market cap of $8.42 billion, a price-to-earnings ratio of 29.11, a PEG ratio of 2.15 and a beta of 0.49. The business has a fifty day moving average of $590.04 and a 200 day moving average of $565.73.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, topping analysts' consensus estimates of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm had revenue of $646.94 million during the quarter, compared to analysts' expectations of $641.78 million. During the same quarter in the prior year, the business earned $5.20 EPS. Chemed's quarterly revenue was up 9.8% compared to the same quarter last year. Equities analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. Chemed's dividend payout ratio is presently 9.74%.

Insider Buying and Selling

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now owns 102,679 shares in the company, valued at $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 3.29% of the stock is owned by insiders.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines